| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Senz Oncology Pty Ltd is a private drug development company leveraging the Australian regulatory framework and taxation environment to conduct time and cost effective development of new cancer therapies. The company has VAL-1000, a small molecule, in Phase I/II clinical trials for acute leukemias. |
| Category: | Health & biotech |
| URL: | http://www.senzoncology.com |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | |
| Address: | ELTHAM VIC 3095 |
| State: | Victoria |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://linkedin.com/company/senz-oncology |
| Founders: | |
| Awards won: | |
